Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-10-26
1997-07-22
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544362, 544363, 544373, 544374, 544376, 544377, 544387, 544388, 546114, 546115, 549 62, 549517, 549527, 549552, 514 43, 514 49, 514220, 5142305, 514252, A61K 31495, C07D40914
Patent
active
056504128
ABSTRACT:
Compounds of formula ##STR1## are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
REFERENCES:
Bigge, et al., "New Preparations of the N-Methyl-D-Aspartate Receptor Antagonist, 4-(3-phosphonopropyl)-2-. . . ", Tet. Lett., vol. 30, No. 39, pp. 5193-5196, 1989.
Caron, et al., "Radioselective Azide Opening of 2,3-Epoxy Alcohols by [Ti(O-i-Pr)2(N3)2]: Synthesis . . . ", J. Org., Chem., 53, pp. 5185-5187, 1988.
Cohen, et al., "Characterization of the Binding Site for Nevirapine (BI-RG-587), a Nonnucleoside Inhibitor . . . ", J. Biol. Chem., vol. 266, No. 22, pp. 14670-14674, 1991.
Felder, et al., "Uber die Katalytische Hydrierung Von Pyrazincarbonsauren", Helv. Chim. Acta, 43(117), pp. 888-896, 1960.
Gao, et al., "Catalytic Asymmetric Epoxidation and Kinetic Resolution: Modified Procedures Including in Situ Derivatization", J. Am. Chen. Soc., 109, pp. 5765-5780, 1987.
Hargrave, et al., "Novel Non-Nucleoside InhibitorsIV-1 Reverse Transcriptase. 1. Tricyclic Pyridobenzo-- and Dipyridodiazepinones", J. Med. Chem., vol. 34, pp. 2231-2241, 1991.
Klunder, et al., "Novel Non-Nucleotide Inhibitors of HIV-1 Reverse Transcriptase. 2. Tricyclic Pyridobenzoxazapinones and Dibenzaxazapinones", J. Chem., vol.34, pp. 2231-2241, 1991.
Winslow et al, AIDS, 8 pp. 753-756 (1994).
Kageyama et al, Antimicrobial Agents and Chemotherapy 36, pp. 926-933 (1992).
Kim Byeong Moon
Vacca Joseph P.
Appollina Mary A.
Bernhardt Emily
Matukaitis Paul D.
Merck & Co. , Inc.
Winokur Melvin
LandOfFree
HIV protease inhibitors useful for the treatment of AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV protease inhibitors useful for the treatment of AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV protease inhibitors useful for the treatment of AIDS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560120